Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 51655-966

3 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Structural Formula)

Structural-formula (Structural Formula)
Chemical structure diagram of Glipizide, the active ingredient in the product. The image shows the molecular configuration including various rings, functional groups, and bonds characteristic of Glipizide.*
FDA Label Image
FDA Label Image

Label (51655 966 26 Rev A 07 23 Nhc)

Label (51655 966 26   Rev A 07 23 Nhc)
Label for Glipizide Extended-Release Tablets, 10 mg, oral dosage form, containing 90 tablets. The label includes storage instructions to keep the product at 20°-25°C and protect it from moisture and humidity. It is marked for prescription use only and is manufactured by Northwind Health Company, LLC with Product NDC 51655-966.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.